dupixent
sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - Παράγοντες για δερματίτιδα, εξαιρουμένων των κορτικοστεροειδών - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.
ompranyt 20mg gastro-resistant capsule, hard
bial-portela & ca, sa (0000003750) a av. da siderurgia nacional, s. mamede do coronado, 4745-457 - omeprazole - gastro-resistant capsule, hard - 20mg - omeprazole (0073590586) 20mg - omeprazole
covexin 10 ενέσιμο εναιώρημα για πρόβατα και βοοειδή
qi02ab01 qi04ab01 - granted - zoetis hellas s.a. - 8900000191 - clostridium perfringens type a toxoid - 0.5 u+; 8900000192 - clostridium perfringens type b & c (Β) toxoid - 18.2 iu; 8900000193 - clostridium perfringens type d (Ε) toxoid - 5.3 iu; 8900000194 - clostridium chauvoei whole culture - 0 iu; 8000001001 - clostridium novyi toxoid - 3.8 iu; 8000001000 - clostridium septicum toxoid - 4.6 iu; 8000001002 - clostridium tetani toxoid - 4.9 iu; 8000001003 - clostridium sordellii toxoid - 4.4 iu; 8900000195 - clostridium haemolyticum toxoid - 17.4 iu - vaccine - vitatrace nutrition ltd
ms-h vaccine
pharmsure veterinary products europe ltd - mycoplasma synoviae στέλεχος ms-Η - Ανοσολογικά προϊόντα για πτηνά (aves), live βακτηριακά εμβόλια - Κοτόπουλο - Για την ενεργητική ανοσοποίηση των μελλοντικών κρεατοπαραγωγής εκτροφέα κοτόπουλων, το μέλλον στρώμα εκτροφέα κοτόπουλων και το μέλλον στρώμα κοτόπουλα για να μειώσει το σάκο αέρα βλάβες και να μειώσει τον αριθμό των αυγών με ανώμαλη shell σχηματισμό που προκαλείται από mycoplasma synoviae.
rasilez
noden pharma dac - αλισκιρένη - Υπέρταση - Παράγοντες που δρουν στο σύστημα ρενίνης-αγγειοτενσίνης - Θεραπεία της ιδιοπαθούς υπέρτασης.
alfoxan 250mg capsule,hard
remedica ltd (0000003171) aharnon str., lemesos, 3056 - mefenamic acid - capsule,hard - 250mg - mefenamic acid (0000061687) 250mg - mefenamic acid
dexa-synto elixir 0.5mg/5ml oral solution
codal-synto limited (0000010484) 21 constantinoupoleos str., limassol, 3011, 51785 (3508) - dexamethasone - oral solution - 0.5mg/5ml - dexamethasone (0000050022) 0,01g - dexamethasone
difene dual release 100mg modified-release capsule, hard
medilink pharmaceuticals ltd (0000003162) 30 armenias, strovolos, 1640, 26576 - diclofenac sodium - modified-release capsule, hard - 100mg - diclofenac sodium (0015307796) 100mg - diclofenac
difene dual release 75mg capsule,hard
medilink pharmaceuticals ltd (0000003162) 30 armenias, strovolos, 1640, 26576 - diclofenac sodium - capsule,hard - 75mg - diclofenac sodium (0015307796) 75mg - diclofenac
ferrous gluconate 300mg film coated tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - ferrous gluconate - film coated tablets - 300mg - ferrous gluconate (0000299296) 320,5mg - ferrous gluconate